Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Current Assets (2016 - 2025)

Historic Current Assets for Orthofix Medical (OFIX) over the last 16 years, with Q3 2025 value amounting to $394.2 million.

  • Orthofix Medical's Current Assets rose 206.0% to $394.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $394.2 million, marking a year-over-year increase of 206.0%. This contributed to the annual value of $433.3 million for FY2024, which is 305.44% up from last year.
  • Orthofix Medical's Current Assets amounted to $394.2 million in Q3 2025, which was up 206.0% from $395.8 million recorded in Q2 2025.
  • Orthofix Medical's 5-year Current Assets high stood at $433.3 million for Q4 2024, and its period low was $246.9 million during Q3 2022.
  • Its 5-year average for Current Assets is $340.7 million, with a median of $386.2 million in 2024.
  • Per our database at Business Quant, Orthofix Medical's Current Assets tumbled by 2477.46% in 2021 and then soared by 6424.2% in 2023.
  • Over the past 5 years, Orthofix Medical's Current Assets (Quarter) stood at $269.5 million in 2021, then dropped by 5.02% to $256.0 million in 2022, then soared by 64.24% to $420.4 million in 2023, then increased by 3.05% to $433.3 million in 2024, then dropped by 9.03% to $394.2 million in 2025.
  • Its Current Assets stands at $394.2 million for Q3 2025, versus $395.8 million for Q2 2025 and $390.3 million for Q1 2025.